Literature DB >> 20890731

The center of accessibility: Dβ control of V(D)J recombination.

Michael L Sikes1, Ruth E McMillan, Justin M Bradshaw.   

Abstract

Developmental patterning of antigen receptor gene assembly in lymphocyte precursors correlates with decondensation of the chromatin surrounding individual gene segments. Ongoing V(D)J recombination is associated with hyperacetylation of histones H3 and H4 and the expression of sterile germline transcripts across the region of recombinational accessibility. Likewise, histone acetyltransferase and SWI/SNF chromatin remodeling complexes each appear to be required for recombination, and the PHD-finger of RAG-2 preferentially associates with recombination signal sequence (RSS) chromatin that contains H3 trimethylated on lysine 4. However, the regulatory mechanisms that direct chromatin alteration and rearrangement have proven elusive, due in large part to the interdependency of individual stages in gene activation, our limited understanding of functional significance of changes to the histone code, and the difficulty of modeling recombinational accessibility in existing experimental systems. Examining Tcrb assembly in developing thymocytes, we review the central roles of RSS elements and germline promoters as foci for epigenetic reorganization of recombinationally accessible gene segments in light of recent findings and persistent questions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20890731      PMCID: PMC3077077          DOI: 10.1007/s00005-010-0101-2

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  69 in total

Review 1.  Enforcing order within a complex locus: current perspectives on the control of V(D)J recombination at the murine T-cell receptor alpha/delta locus.

Authors:  Michael S Krangel; Juan Carabana; Iratxe Abbarategui; Ryan Schlimgen; Abbas Hawwari
Journal:  Immunol Rev       Date:  2004-08       Impact factor: 12.988

Review 2.  Regulation of activation and recombination of the murine Igkappa locus.

Authors:  Mark S Schlissel
Journal:  Immunol Rev       Date:  2004-08       Impact factor: 12.988

Review 3.  Selection of the T-cell repertoire: receptor-controlled checkpoints in T-cell development.

Authors:  Harald von Boehmer
Journal:  Adv Immunol       Date:  2004       Impact factor: 3.543

Review 4.  Regulation of immunoglobulin heavy-chain gene rearrangements.

Authors:  Dipanjan Chowdhury; Ranjan Sen
Journal:  Immunol Rev       Date:  2004-08       Impact factor: 12.988

5.  Genes encoding the T-cell receptor alpha and beta subunits are transcribed in an ordered manner during intrathymic ontogeny.

Authors:  H D Royer; D Ramarli; O Acuto; T J Campen; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

6.  Developmentally controlled and tissue-specific expression of unrearranged VH gene segments.

Authors:  G D Yancopoulos; F W Alt
Journal:  Cell       Date:  1985-02       Impact factor: 41.582

Review 7.  Regulation of genome rearrangement events during lymphocyte differentiation.

Authors:  F W Alt; T K Blackwell; R A DePinho; M G Reth; G D Yancopoulos
Journal:  Immunol Rev       Date:  1986-02       Impact factor: 12.988

8.  Rearrangement of T-cell receptor beta-chain genes during T-cell development.

Authors:  W Born; J Yagüe; E Palmer; J Kappler; P Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

Review 9.  Regulation of T-cell receptor beta-chain gene assembly by recombination signals: the beyond 12/23 restriction.

Authors:  Robert E Tillman; Andrea L Wooley; Maureen M Hughes; Bernard Khor; Barry P Sleckman
Journal:  Immunol Rev       Date:  2004-08       Impact factor: 12.988

10.  Ordered rearrangement of immunoglobulin heavy chain variable region segments.

Authors:  F W Alt; G D Yancopoulos; T K Blackwell; C Wood; E Thomas; M Boss; R Coffman; N Rosenberg; S Tonegawa; D Baltimore
Journal:  EMBO J       Date:  1984-06       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.